Management of Psychiatric Disease in Hepatitis C Treatment Candidates.
Management of Psychiatric Disease in Hepatitis C Treatment Candidates.
复制标题
DOI：
10.1007/s11901-010-0035-5
复制
发表时间：
2010-04-06
期刊：
影响因子：
--
通讯作者：
Lotrich, Francis
中科院分区：
文献类型：
--
作者：
Lotrich, Francis
抑郁和其他对心理健康的影响可能会影响慢性丙型肝炎治疗期间的抗病毒反应率，这些患者的生活质量以及自杀等不良后果的风险。增强接受干扰素-α治疗的患者的治疗效果需要1）解决预先存在的心理健康问题，2）缓解治疗期间出现的精神疾病，3）预测和预防这些疾病。越来越多的证据表明，这三个目标是可行的。在这方面，精神病管理的合作参与往往是至关重要的。
Depression and other influences on mental health can impact antiviral response rates during chronic hepatitis C treatment, the quality of life for these patients, and the risk for adverse outcomes such as suicide. Enhanced treatment outcomes for patients who are receiving interferon-alpha requires 1) addressing preexisting mental health problems, 2) alleviating psychiatric conditions that emerge during treatment, and 3) prediction and prevention of these conditions. Accumulating evidence indicates that these three goals are feasible. Collaborative involvement of psychiatric management may often be critical in this regard.